Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation.
Front Oncol
; 12: 998274, 2022.
Article
in En
| MEDLINE
| ID: mdl-36531071
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Front Oncol
Year:
2022
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland